To further explore the involvement of TREM2+ cells in the progression of HCC, an orthotopic HCC mouse model was established by injecting Hepa 1–6 cells intrahepatically into wild-type (WT) and Trem2-knockout (Trem2−/−) mice. The gene discussed is TREM2; the disease is hepatocellular carcinoma.